Found 323 results for new-alliance

Check It Out: Iconic New York Deal Toys… from MSG to Manischewitz

August 20, 2015 by David Parry

No, we’re not talking about New York souvenirs. Foam Statue of Liberty crowns. Big Apple shot...

 Blog Post

Australia and New Zealand Deal Toys: Trolls, Sneaker Frenzies & More!

September 2, 2016 by David Parry

Wait a minute. Hong Kong gamers? German sneakers? Brazilian gold mines? Hollywood...

 Blog Post

Newsy/Scripps Custom iPhone Lucite

Custom Lucite recognizing the acquisition of Columbia, Missouri-based video news provider Newsy by Scripps. Headquartered in Cincinnati, Ohio, Scripps owns 19 local television stations and daily newspapers in 13 markets across the U.S.

1 Image

The $41 Billion London-New York Deal Stolen in The Night

November 10, 2022 by David Parry

Of all the deal toys The Corporate Presence has created for clients over its forty-year history,...

 Blog Post

Vodafone New Zealand Deal Tombstone

Crystal deal tombstone marking the sale of Vodafone New Zealand, New Zealand’s largest mobile company. The acquirers were Infratil, a New Zealand-based investment company, and Brookfield Asset Management, a Canadian firm.

(9LJW171)
1 Image

Australia and New Zealand Deal Toys: A Gallery of Recent Highlights

January 8, 2016 by David Parry

Most bankers love looking at deal toys. Particularly those done by rival banks…and even if...

 Blog Post

Deal Toys Deconstructed: See What a New Documentary Reveals

February 9, 2015 by David Parry

A new documentary offers an outsider’s perspective on not only the nature of deal toys, but also...

 Blog Post

Newscorp Deal Toy

Deal toy involving American and Australian operations of News Corp.

1 Image

New Drug Application Custom Crystal

Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.

(20ALJ356)
2 Images
Crystal commemorative marking the submission to the Food and Drug Administration (FDA) of a New Drug Application (NDA). INP104 was developed for the acute treatment of migraine headaches.